Akanda Corp

Healthcare US AKAN

15.695USD
-0.485(3.00%)

Last update at 2026-06-24T17:39:00Z

Day Range

14.8016.09

LowHigh

52 Week Range

2.30121.06

LowHigh

Fundamentals

Previous Close 16.18
Market Cap1.74M
Volume22433
P/E Ratio-
Dividend Yield-%
EBITDA-3.67802M
Revenue TTM0.84M
Revenue Per Share TTM31.12
Gross Profit TTM 0.21M
Diluted EPS TTM696.80

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Income before tax	-3.26841M	-32.27507M	-8.23545M	-8.13120M	-2.30057M
Minority interest	-	-	-	-	-
Net income	-4.09603M	-32.27507M	0.40M	-9.22413M	-2.94597M
Selling general administrative	4.45M	5.88M	19.85M	5.81M	1.36M
Selling and marketing expenses	-	2.40M	-	-	-
Gross profit	0.21M	0.11M	3.27M	-0.71473M	0.00025M
Reconciled depreciation	0.14M	4.28M	3.76M	0.31M	0.25M
Ebit	-3.16830M	-32.01942M	-20.17639M	-6.83373M	-1.66583M
Ebitda	-3.02725M	-27.73569M	-16.41152M	-6.49790M	-1.40654M
Depreciation and amortization	0.14M	4.28M	3.76M	0.34M	0.26M
Non operating income net other	-	-	-	-	-
Operating income	-4.38248M	-10.05137M	-20.17639M	-6.83373M	-1.66583M
Other operating expenses	5.22M	12.21M	22.80M	6.88M	1.67M
Interest expense	0.10M	0.26M	0.12M	1.09M	0.65M
Tax provision	-	-	-	-	-
Interest income	0.00649M	0.00004M	0.00089M	0.03M	0.01M
Net interest income	-0.09362M	-0.25562M	-0.11444M	-1.06613M	-0.63497M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-0.00000M	-8.63249M	1.09M	0.65M
Total revenue	0.84M	2.16M	2.62M	0.04M	0.00206M
Total operating expenses	4.59M	10.16M	23.45M	6.12M	1.67M
Cost of revenue	0.63M	2.05M	-0.64988M	0.76M	0.00181M
Total other income expense net	1.11M	-22.22370M	11.94M	-1.29747M	-0.63474M
Discontinued operations	-	-	-3.42223M	-3.42223M	-3.42223M
Net income from continuing ops	-3.26841M	-32.27507M	-8.23545M	-8.13120M	-2.30057M
Net income applicable to common shares	-	-	-11.65767M	-8.13120M	-2.30057M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Total assets	7.91M	8.84M	39.00M	8.05M	4.27M
Intangible assets	0.02M	3.80M	22.21M	0.26M	0.32M
Earning assets	-	-	-	-	-
Other current assets	0.39M	0.14M	0.81M	484886.00M	0.11M
Total liab	3.64M	12.67M	12.10M	10.25M	9.31M
Total stockholder equity	4.28M	-3.82889M	26.90M	-2.20142M	-5.03194M
Deferred long term liab	-	-	-	-	-
Other current liab	0.30M	2.66M	1.06M	8268428.00M	-
Common stock	63.32M	51.02M	49.43M	7.26M	0.00164M
Capital stock	63.32M	51.02M	49.43M	7.26M	0.00164M
Retained earnings	-57.45906M	-53.36303M	-21.08796M	-13.29389M	-5.16269M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	0.48M	-	-
Cash	3.84M	0.09M	0.23M	3.50M	0.01M
Cash and equivalents	-	-	-	-	-
Total current liabilities	3.64M	10.17M	9.35M	8.27M	2.73M
Current deferred revenue	-	-	-	-8268428.00000M	-
Net debt	-3.48584M	3.90M	3.67M	6.07M	9.11M
Short term debt	0.35M	1.50M	1.15M	7.59M	2.55M
Short long term debt	0.35M	1.37M	0.94M	7.15M	2.26M
Short long term debt total	0.35M	4.00M	3.90M	9.57M	9.12M
Other stockholder equity	-	-	-1.44657M	11092467.00M	0.13M
Property plant equipment	-	-	12.48M	3.81M	3.83M
Total current assets	5.06M	1.81M	3.82M	3.98M	0.13M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	4.69M	-2.46052M	-5.35335M
Short term investments	-	0.00000M	0.26M	-	-
Net receivables	0.82M	0.28M	1.24M	0.24M	0.00000M
Long term debt	-	2.50M	2.63M	-	3.98M
Inventory	0.00000M	1.29M	1.06M	-484885.75747M	0.00061M
Accounts payable	2.98M	6.01M	7.14M	0.68M	0.18M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-1.58380M	-1.48598M	-1.44657M	3.84M	0.13M
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	0.50M	0.59M	0.48M	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	2.86M	7.03M	35.18M	4.07M	4.15M
Capital lease obligations	0.00000M	0.14M	0.33M	2.42M	2.88M
Long term debt total	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Investments	-1.01616M	0.02M	-4.21866M	-0.57647M	-0.43220M
Change to liabilities	-	-	2.92M	0.00000M	0.14M
Total cashflows from investing activities	-1.01616M	0.02M	-4.21866M	-0.57647M	-0.43220M
Net borrowings	-0.33964M	-0.08358M	-0.79444M	6.18M	1.03M
Total cash from financing activities	8.99M	1.49M	14.14M	11.24M	1.03M
Change to operating activities	-	-	-0.64310M	0.37M	-0.10984M
Net income	-4.09603M	-32.27507M	-11.65767M	-8.13120M	-2.30057M
Change in cash	3.75M	-0.16193M	-3.23959M	3.48M	-0.80606M
Begin period cash flow	0.09M	0.26M	3.50M	0.01M	0.82M
End period cash flow	3.84M	0.09M	0.26M	3.50M	0.01M
Total cash from operating activities	-3.98036M	-1.50057M	-11.46940M	-6.55706M	-1.35247M
Issuance of capital stock	10.75M	0.00000M	14.93M	5.05M	0.00148M
Depreciation	0.14M	4.28M	3.76M	0.31M	0.25M
Other cashflows from investing activities	-0.36660M	0.03M	-0.73995M	-0.73995M	0.00693M
Dividends paid	-	-	-	-	-
Change to inventory	0.37M	0.48M	0.50M	-0.71252M	-0.00061M
Change to account receivables	-0.25468M	0.97M	-0.59107M	-0.24236M	-0.24236M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-1.42587M	1.57M	0.50M	6.68M	1.17M
Change to netincome	-	-	-5.75785M	1.85M	0.67M
Capital expenditures	2.10M	0.00150M	0.31M	0.58M	0.44M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	-0.95031M	3.15M	2.18M	-0.58750M	0.03M
Stock based compensation	-	1.25M	0.56M	-	-
Other non cash items	0.92M	23.34M	-6.31707M	1.85M	0.67M
Free cash flow	-6.07850M	-1.50208M	-11.78034M	-7.13353M	-1.79160M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
AKAN Akanda Corp	-0.485 3.00%	15.70	-	-	2.08	0.55	0.44	-0.7955
ZTS Zoetis Inc	1.03 1.34%	77.87	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	0.83 2.69%	31.72	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	155.71	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	1.49 3.43%	44.91	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

Akanda Corp

100 King St. W, Toronto, ON, Canada, M5X 1G5

416 862 7525
https://www.akandacorp.com

Key Executives

Name	Title	Year Born
Ms. Louisa Madiako Mojela B.Com., B.Comm	Exec. Chairman	1956
Mr. Tejinder Virk	CEO & Director	1982
Mr. Trevor W. Scott BAcc, BCom (Hons), CA(SA)	CFO & Sec.	1980
Mr. Thomas Flow	Chief Operating Officer	1977
Ms. Katharyn Field	Interim CEO & Executive Director	1984
Dr. Gurcharn Deol B.A., M.A., Ph.D.	Chief Financial Officer	1950
Mr. Thomas Flow	Chief Operating Officer	1978
Ms. Katharyn Field	Interim CEO & Executive Director	1983
Dr. Gurcharn Deol B.A., M.A., Ph.D.	Chief Financial Officer	1968
Dr. Gurcharn Deol B.A., M.A., Ph.D.	Chief Financial Officer	1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.